aminolevulinic acid has been researched along with Rosacea in 8 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Rosacea: A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
| Excerpt | Relevance | Reference |
|---|---|---|
| "5-Aminolevulinic acid photodynamic therapy (ALA-PDT) showed potential to treat rosacea according to recent studies; however, a lack of clinical evidence and unclear adverse effects limit its use." | 9.69 | 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. ( Cao, Y; Chen, Q; Liu, X; Wang, P; Wang, X; Yang, J; Yang, Y; Zeng, Q; Zhang, H; Zhang, L, 2023) |
| "To compare the effect of ALA-PDT vs minocycline on rosacea." | 9.69 | 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. ( Cao, Y; Chen, Q; Liu, X; Wang, P; Wang, X; Yang, J; Yang, Y; Zeng, Q; Zhang, H; Zhang, L, 2023) |
| "In this single-center, randomized, evaluator-blind, controlled study, patients with moderate-to-severe rosacea were allocated to receive 3 to 5 sessions of ALA-PDT or 8 weeks of 100 mg daily minocycline treatment, followed by a 24-week follow-up." | 9.69 | 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. ( Cao, Y; Chen, Q; Liu, X; Wang, P; Wang, X; Yang, J; Yang, Y; Zeng, Q; Zhang, H; Zhang, L, 2023) |
| "As minocycline does, ALA-PDT can improve rosacea mainly in papulopustular lesions and patients' quality of life, indicating a new option for rosacea." | 9.69 | 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. ( Cao, Y; Chen, Q; Liu, X; Wang, P; Wang, X; Yang, J; Yang, Y; Zeng, Q; Zhang, H; Zhang, L, 2023) |
| "A 72-year-old woman suffering from multiple actinic keratosis (AK) complicating steroid-induced rosacea received 5-aminolevulinic acid-photodynamic therapy (ALA-PDT) in our outpatient clinic." | 8.12 | Inflammation burst after 5-aminolevulinic acid-photodynamic therapy for the treatment of actinic keratosis complicating rosacea: A case report. ( Cao, Y; Hu, C; Liu, P; Liu, X; Wang, P; Wang, X; Yang, X; Zhang, L, 2022) |
| "5-Aminolevulinic acid photodynamic therapy (ALA-PDT) showed potential to treat rosacea according to recent studies; however, a lack of clinical evidence and unclear adverse effects limit its use." | 5.69 | 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. ( Cao, Y; Chen, Q; Liu, X; Wang, P; Wang, X; Yang, J; Yang, Y; Zeng, Q; Zhang, H; Zhang, L, 2023) |
| "To compare the effect of ALA-PDT vs minocycline on rosacea." | 5.69 | 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. ( Cao, Y; Chen, Q; Liu, X; Wang, P; Wang, X; Yang, J; Yang, Y; Zeng, Q; Zhang, H; Zhang, L, 2023) |
| "In this single-center, randomized, evaluator-blind, controlled study, patients with moderate-to-severe rosacea were allocated to receive 3 to 5 sessions of ALA-PDT or 8 weeks of 100 mg daily minocycline treatment, followed by a 24-week follow-up." | 5.69 | 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. ( Cao, Y; Chen, Q; Liu, X; Wang, P; Wang, X; Yang, J; Yang, Y; Zeng, Q; Zhang, H; Zhang, L, 2023) |
| "As minocycline does, ALA-PDT can improve rosacea mainly in papulopustular lesions and patients' quality of life, indicating a new option for rosacea." | 5.69 | 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. ( Cao, Y; Chen, Q; Liu, X; Wang, P; Wang, X; Yang, J; Yang, Y; Zeng, Q; Zhang, H; Zhang, L, 2023) |
| "A 72-year-old woman suffering from multiple actinic keratosis (AK) complicating steroid-induced rosacea received 5-aminolevulinic acid-photodynamic therapy (ALA-PDT) in our outpatient clinic." | 4.12 | Inflammation burst after 5-aminolevulinic acid-photodynamic therapy for the treatment of actinic keratosis complicating rosacea: A case report. ( Cao, Y; Hu, C; Liu, P; Liu, X; Wang, P; Wang, X; Yang, X; Zhang, L, 2022) |
| "Rosacea is a common chronic cutaneous disorder which is characterized by flushing, erythema, papulopustules and telangiectasia." | 2.87 | Photodynamic therapy for rosacea in Chinese patients. ( Fan, L; Hamblin, MR; Lan, T; Yin, R, 2018) |
| "Rosacea is a common disease that often has a chronic intermittent course despite current treatment; therefore, additional treatment options are desirable." | 1.34 | Photodynamic therapy in a series of rosacea patients. ( Bryld, LE; Jemec, GB, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Li, A | 1 |
| Fang, R | 1 |
| Mao, X | 1 |
| Sun, Q | 1 |
| Liu, P | 1 |
| Liu, X | 2 |
| Wang, P | 2 |
| Zhang, L | 2 |
| Hu, C | 1 |
| Yang, X | 1 |
| Cao, Y | 2 |
| Wang, X | 2 |
| Yang, J | 1 |
| Zhang, H | 1 |
| Chen, Q | 1 |
| Yang, Y | 1 |
| Zeng, Q | 1 |
| Sun, Y | 1 |
| Chen, L | 1 |
| Zhang, Y | 1 |
| Gao, X | 1 |
| Wu, Y | 1 |
| Chen, H | 1 |
| Fan, L | 1 |
| Yin, R | 1 |
| Lan, T | 1 |
| Hamblin, MR | 1 |
| Friedmann, DP | 1 |
| Goldman, MP | 1 |
| Fabi, SG | 1 |
| Guiha, I | 1 |
| Katz, B | 1 |
| Patel, V | 1 |
| Bryld, LE | 1 |
| Jemec, GB | 1 |
1 review available for aminolevulinic acid and Rosacea
| Article | Year |
|---|---|
Photodynamic therapy in the treatment of rosacea: A systematic review.
Topics: Adolescent; Adult; Aged; Aminolevulinic Acid; Humans; Lasers, Dye; Light; Middle Aged; Photochemothe | 2022 |
2 trials available for aminolevulinic acid and Rosacea
| Article | Year |
|---|---|
5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study.
Topics: Aminolevulinic Acid; Humans; Minocycline; Photochemotherapy; Photosensitizing Agents; Quality of Lif | 2023 |
Photodynamic therapy for rosacea in Chinese patients.
Topics: Adult; Aminolevulinic Acid; Asian People; China; Emulsions; Female; Humans; Male; Middle Aged; Photo | 2018 |
5 other studies available for aminolevulinic acid and Rosacea
| Article | Year |
|---|---|
Inflammation burst after 5-aminolevulinic acid-photodynamic therapy for the treatment of actinic keratosis complicating rosacea: A case report.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Hyperpigmentation; Inflammation; Keratosis, Actinic; Phot | 2022 |
Topical photodynamic therapy with 5-aminolevulinic acid in Chinese patients with Rosacea.
Topics: Adult; Aminolevulinic Acid; China; Female; Humans; Male; Middle Aged; Patient Satisfaction; Photoche | 2019 |
Multiple sequential light and laser sources to activate aminolevulinic acid for rosacea.
Topics: Aminolevulinic Acid; Color; Female; Humans; Intense Pulsed Light Therapy; Lasers, Dye; Male; Middle | 2016 |
Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea.
Topics: Aminolevulinic Acid; Erythema; Female; Flushing; Humans; Middle Aged; Photochemotherapy; Photosensit | 2006 |
Photodynamic therapy in a series of rosacea patients.
Topics: Adult; Aged; Aminolevulinic Acid; Dermatologic Agents; Female; Humans; Male; Middle Aged; Photochemo | 2007 |